{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/constipation/management/adults/","result":{"pageContext":{"chapter":{"id":"e7e6858e-631c-50fa-b152-6f3e159172f2","slug":"adults","fullItemName":"Scenario: Adults","depth":2,"htmlHeader":"<!-- begin field 7ed15573-16cb-45d5-b6c0-a854fd1f2330 --><h2>Scenario: Constipation in adults</h2><!-- end field 7ed15573-16cb-45d5-b6c0-a854fd1f2330 -->","summary":"Covers the management of constipation in adults (including pregnant women and those who are breastfeeding), for short-duration and chronic constipation, and faecal loading and/or impaction.","htmlStringContent":"<!-- begin item 480d813a-1ae3-405c-876e-e8950e0f2078 --><!-- begin field 529edea3-b62e-4dc8-b88c-acd900aba782 --><p>From age 18 years onwards.</p><!-- end field 529edea3-b62e-4dc8-b88c-acd900aba782 --><!-- end item 480d813a-1ae3-405c-876e-e8950e0f2078 -->","topic":{"id":"88cc63e8-cda0-5ec1-9109-ae5f4bfa11e3","topicId":"f48a0909-280f-4498-b297-07190c08ba54","topicName":"Constipation","slug":"constipation","lastRevised":"Last revised in November 2020","chapters":[{"id":"652b9d37-6de5-5916-9013-64708458d208","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"602fea2a-9883-51cc-9131-86d54e1113e9","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"eae1c7f5-9d3d-5ff3-a31a-7ff5aa5d2b7f","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"f4d419f5-dfbc-54c7-b9e9-89991528af48","slug":"changes","fullItemName":"Changes"},{"id":"f186f2b1-9c45-56b4-a1b7-8f5a64a55f86","slug":"update","fullItemName":"Update"}]},{"id":"c2b304c9-3b12-5ee7-81ca-b9ea44de8ad2","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"1f8da0ad-6b3f-5b74-b978-502804c2464e","slug":"goals","fullItemName":"Goals"},{"id":"094c26e0-e5de-57ad-8f83-0874e217917b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"183d066c-25c1-5ad6-91ad-2f1ddaf48844","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5728a841-2eb8-5a93-928f-78962810589e","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e8aec3c8-dcd5-529d-b1e6-4e64bf325751","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b41e9ad7-b6f1-5370-9ab2-824d00965a97","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"644e0758-3407-5c39-b900-549da92e4b67","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"793f8115-0d16-56ae-9aa8-36081e7b05c1","slug":"definition","fullItemName":"Definition"},{"id":"845578b1-5eae-5964-be4f-428a0e1b7917","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e98889d3-a808-5164-9182-e7e91ec41a5a","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"ffec4b77-cf61-5457-a0f5-ce1e0f586efd","slug":"secondary-causes","fullItemName":"Secondary causes"},{"id":"2ee90a5b-045c-53d9-b959-152df5ad7f47","slug":"complications","fullItemName":"Complications"},{"id":"43476423-3756-5b1e-9830-62652bc204fa","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"20a02d1d-6083-5d12-9a37-2341374ee49e","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"0fb11d37-0b97-560c-9521-31e3e92b8521","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"59b36c20-e883-5b08-b36a-485a711db9da","slug":"assessment","fullItemName":"Assessment"}]},{"id":"af868597-08db-5b93-8dad-450f291d1a9e","fullItemName":"Management","slug":"management","subChapters":[{"id":"e7e6858e-631c-50fa-b152-6f3e159172f2","slug":"adults","fullItemName":"Scenario: Adults"}]},{"id":"01aa9990-5973-577b-83b3-984de168d2ec","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"c8b1ca22-3ea7-54d7-a60e-085a99978b86","slug":"choice-of-laxatives","fullItemName":"Choice of laxatives"},{"id":"c6802d37-3b6e-56ae-b981-bf5a1fa73dfa","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions"},{"id":"a9857941-fb3d-5c45-a169-a10e8b051874","slug":"factors-affecting-choice-of-laxative","fullItemName":"Factors affecting choice of laxative"},{"id":"07a053e7-81a8-5cdd-a703-648169d42d57","slug":"adverse-effects-of-laxatives","fullItemName":"Adverse effects of laxatives"}]},{"id":"5c976ceb-9cd2-5109-96f3-46103c161ded","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"b23b11d4-8313-5155-aa23-31f0a397d85d","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"fdead64f-db75-5e71-bab5-4a4fb444a78e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"e902c099-4ac5-500b-90a6-fee9ea7e517f","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"48884da3-b344-59b5-9e59-a14de8e35504","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"9e2d6345-692d-564f-8200-2d89db123fc2","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"cca0beff-c1e5-54df-88e2-1b00d48dfeb0","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"632aae60-b457-578c-9502-2e434b5ca3e0","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"af868597-08db-5b93-8dad-450f291d1a9e","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"a8505c69-7480-55c5-8ae8-4aa80edc1af8","slug":"initial-self-management","fullItemName":"Initial self-management","depth":3,"htmlHeader":"<!-- begin field 3ff4122c-99b4-4389-9921-d20e561358bb --><h3>What self-management advice should I give?</h3><!-- end field 3ff4122c-99b4-4389-9921-d20e561358bb -->","summary":null,"htmlStringContent":"<!-- begin item 9472f4e1-91f4-4162-a202-edbd6a967cb0 --><!-- begin field 2e7b33af-0d60-4813-b996-4f69d3e7cb16 --><p><strong>Encourage the person or carer to manage their symptoms by giving advice on:</strong></p><ul><li>Sources of information and support, such as:<ul><li>The NHS patient information leaflets on <a href=\"https://www.nhs.uk/conditions/constipation/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"c4d518f3-45f5-43d9-8d90-a98d011d8a7d\">Constipation</a> and <a href=\"https://www.nhs.uk/conditions/bowel-incontinence/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"50fc5b78-82bf-47a2-a0fe-a98d011d8b48\">Bowel incontinence</a>.</li></ul></li><li>Eating a healthy, balanced diet and having regular meals:<ul><li>The person's diet should contain whole grains, fruits (and their juices) high in sorbitol, and vegetables.<ul><li>Fruits that have a high sorbitol content include apples, apricots, grapes (and raisins), peaches, pears, plums (and prunes), raspberries, and strawberries.</li><li>The Association of UK Dietitians has useful Food Fact Sheets on <a href=\"https://www.bda.uk.com/foodfacts/fibrefoodfactsheet.pdf\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"fbb34c8b-dc75-483d-ab11-a98d011d8ba2\">Fibre</a> and <a href=\"https://www.bda.uk.com/foodfacts/FruitVeg.pdf\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"48d32842-e433-4ff6-8929-a98d011d8c02\">Fruit and vegetables - how to get five-a-day</a>.</li></ul></li><li>Fibre intake should be increased gradually (to minimize flatulence and bloating) — adults should aim to consume 30 g of fibre per day.<ul><li>Advise the person that the beneficial effects of increasing dietary fibre may take several weeks.</li></ul></li><li>Public Health England's booklet <a href=\"https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/551502/Eatwell_Guide_booklet.pdf\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"a28bf593-d41c-4a97-9972-a98d011d8cb9\">The Eatwell Guide</a> has patient information on eating a healthy, balanced diet.</li></ul></li><li>Drinking an adequate fluid intake, especially if there is a risk of dehydration.<ul><li>The Association of UK Dietitians has a useful Food Fact Sheet on <a href=\"https://www.bda.uk.com/resource/fluid-water-drinks.html\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"0d6d8022-da9e-4e1a-8122-a98d011d8cf1\">Fluid</a>.</li></ul></li><li>Increasing activity and exercise levels, if needed.</li><li>Helpful toileting routines:<ul><li>Advise on a regular, unhurried toilet routine, giving time to ensure that defecation is complete.</li><li>Advise on responding immediately to the sensation of needing to defecate.</li><li>Ensure that people with limited mobility have appropriate help to access the toilet and adequate privacy.</li><li>Ensure the person has access to supported seating if they are unsteady on the toilet.</li></ul></li></ul><!-- end field 2e7b33af-0d60-4813-b996-4f69d3e7cb16 --><!-- end item 9472f4e1-91f4-4162-a202-edbd6a967cb0 -->","subChapters":[{"id":"7377a13e-65ce-59bb-a4b0-97ca3d91aab0","slug":"basis-for-recommendation-667","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field f7aed8e2-6a7a-41cc-b24c-4fd7d1daf0d6 --><h4>Basis for recommendation</h4><!-- end field f7aed8e2-6a7a-41cc-b24c-4fd7d1daf0d6 -->","summary":null,"htmlStringContent":"<!-- begin item 6676e5ac-8181-4391-bf61-9c4c573a6ca3 --><!-- begin field e582e434-afd6-4a3d-bedd-b8061a171468 --><p>The recommendations on the initial management of constipation are based on the Northern Ireland Centre for Pharmacy Learning and Development COMPASS publication <em>Therapeutic notes on the management of chronic constipation in primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">COMPASS, 2016</a>], the American Gastroenterological Association (AGA) <em>Technical review on constipation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Bharucha, 2013a</a>], the American College of Gastroenterology (ACG) <em>Monograph on the management of irritable bowel syndrome and chronic idiopathic constipation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Ford, 2014</a>], a meta-analysis on the effect of dietary fibre on constipation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Yang, 2012</a>], and expert opinion in review articles on constipation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Jamshed, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Mounsey, 2015</a>].</p><ul><li>The AGA technical review notes that there is no evidence that constipation can be treated by increasing fluid intake unless there is evidence of dehydration, and cites evidence that increasing physical activity can improve constipation symptoms [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Bharucha, 2013a</a>].</li><li>The ACG monograph found low-quality evidence that dietary fibre supplements increase stool frequency in people with chronic idiopathic constipation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Ford, 2014</a>]. In addition, a meta-analysis of five randomized controlled trials (RCTs) found that dietary fibre increased stool frequency compared with placebo, but there was no significant difference in stool consistency, treatment success, laxative use, and painful defecation end-points between the two groups [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Yang, 2012</a>].</li><li>The recommendations on helpful toileting routines are based on expert opinion in a review article on the management of constipation in older adults [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Mounsey, 2015</a>], and are pragmatic, based on what CKS considers to be good medical practice.</li></ul><!-- end field e582e434-afd6-4a3d-bedd-b8061a171468 --><!-- end item 6676e5ac-8181-4391-bf61-9c4c573a6ca3 -->","subChapters":[]}]},{"id":"7abf2add-1046-5a07-ae51-074e068f5e86","slug":"short-duration-constipation","fullItemName":"Short-duration constipation","depth":3,"htmlHeader":"<!-- begin field edfcd91f-61cb-44d0-a027-2c84a060d6f8 --><h3>How should I manage short-duration constipation?</h3><!-- end field edfcd91f-61cb-44d0-a027-2c84a060d6f8 -->","summary":null,"htmlStringContent":"<!-- begin item f35028ba-c7e7-4dc5-a2f2-99e18d178807 --><!-- begin field 3e7abaa0-826c-46a5-8f66-55ea6994e9fc --><p><strong>For the management of short-duration constipation:</strong></p><ul><li>Manage any underlying <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/background-information/secondary-causes/\">secondary cause</a> of constipation, and advise the person to reduce or stop any <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/background-information/secondary-causes/\">drug treatment</a> that may be causing or contributing to symptoms, if possible and appropriate.</li><li>Advise on <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/management/adults/#initial-self-management\">lifestyle measures</a>, such as increasing dietary fibre, fluid intake, and activity levels.</li><li>If these measures are ineffective, or symptoms do not respond adequately, offer treatment with oral laxatives using a stepped approach:<ul><li>Offer a bulk-forming laxative first-line, such as ispaghula. Note: it is important for the person to drink an adequate fluid intake.</li><li>If stools remain hard or difficult to pass, add or switch to an osmotic laxative, such as a macrogol.<ul><li>If a macrogol is ineffective or not tolerated, offer treatment with lactulose second-line.</li></ul></li><li>If stools are soft but difficult to pass, or there is a sensation of inadequate emptying, add a stimulant laxative.</li><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/prescribing-information/\">Prescribing information</a> for more information on laxative choices and factors to consider before prescribing different laxatives.</li></ul></li><li>If the person has opioid-induced constipation:<ul><li>Do not prescribe bulk-forming laxatives.</li><li>Offer an osmotic laxative and a stimulant laxative (or docusate is an alternative which also has stool-softening properties).</li></ul></li><li>Advise the person to <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/management/adults/#follow-up-in-primary-care\">gradually reduce</a> and stop laxatives once the person is producing soft, formed stool without straining at least three times per week.</li><li>Arrange to review the person regularly, depending on clinical judgement. See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/management/adults/#follow-up-in-primary-care\">How should I follow up a person in primary care?</a> for more information.</li></ul><!-- end field 3e7abaa0-826c-46a5-8f66-55ea6994e9fc --><!-- end item f35028ba-c7e7-4dc5-a2f2-99e18d178807 -->","subChapters":[{"id":"8f7e72ec-a3e1-5d33-97f5-d28f2e35c2eb","slug":"basis-for-recommendation-6e5","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field aabdee6d-ab98-4ec5-aa39-eacfc482a19d --><h4>Basis for recommendation</h4><!-- end field aabdee6d-ab98-4ec5-aa39-eacfc482a19d -->","summary":null,"htmlStringContent":"<!-- begin item 6e50b869-3368-4277-bff2-24ee979d0d79 --><!-- begin field 8eeabb09-a2b0-4f4e-9d7c-548bd9ff41cf --><p>The recommendations on the management of short-duration constipation have been extrapolated from expert opinion in the World Gastroenterology Organisation (WGO) Global Guidelines <em>Constipation: a global perspective</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">WGO, 2010</a>], the Northern Ireland Centre for Pharmacy Learning and Development COMPASS publication <em>Therapeutic notes on the management of chronic constipation in primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">COMPASS, 2016</a>], a Cochrane systematic review <em>Lactulose versus polyethylene glycol for chronic constipation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Lee-Robichaud et al, 2010</a>], and expert opinion in review articles on constipation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Tack, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Mounsey, 2015</a>] and opioid-induced constipation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Goodheart and Leavitt, 2006</a>]. They are also pragmatic, based on what CKS considers to be good clinical practice.</p><h5>Choice of laxatives</h5><ul><li>Evidence for the efficacy and safety of some of the older laxatives from well-designed trials is limited, as there is a lack of head-to-head comparative studies to determine whether one laxative class is superior to another [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Tack, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">COMPASS, 2016</a>].<ul><li>The recommendation on osmotic laxatives is extrapolated from a Cochrane systematic review meta-analysis of 10 randomized controlled trials (RCTs) comparing lactulose and the macrogol polyethylene glycol (PEG) in the treatment of chronic constipation, which found that PEG was superior to lactulose in outcomes of stool frequency per week, stool consistency, abdominal pain, and the need for additional medication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Lee-Robichaud et al, 2010</a>].</li></ul></li></ul><h5>Treating opioid-induced constipation</h5><ul><li>The recommendations on treating opioid-induced constipation are based on expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Goodheart and Leavitt, 2006</a>].<ul><li>Bulk-forming laxatives are not recommended as their mode of action is to distend the colon and stimulate peristalsis, but opioids prevent the colon responding with propulsive action. This may cause abdominal colic and rarely bowel obstruction.</li><li>Osmotic laxatives retain fluid in the stool making defecation easier, and docusate also has stool-softening properties.</li><li>Stimulant laxatives overcome the reduced peristalsis caused by opioid medication.</li></ul></li></ul><!-- end field 8eeabb09-a2b0-4f4e-9d7c-548bd9ff41cf --><!-- end item 6e50b869-3368-4277-bff2-24ee979d0d79 -->","subChapters":[]}]},{"id":"d5627e19-e7dc-55d1-a26a-560ba723f7cc","slug":"chronic-constipation","fullItemName":"Chronic constipation","depth":3,"htmlHeader":"<!-- begin field 93a5bb9a-7a37-4d24-b11d-29e721801591 --><h3>How should I manage chronic constipation?</h3><!-- end field 93a5bb9a-7a37-4d24-b11d-29e721801591 -->","summary":null,"htmlStringContent":"<!-- begin item 6e5968c6-77a4-4926-abff-34000ba02dcb --><!-- begin field 7146c388-a7a3-4858-ba4a-04f1e66e2278 --><ul><li>For the initial management of chronic constipation:<ul><li>Manage any underlying <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/background-information/secondary-causes/\">secondary cause</a> of constipation, and advise the person to reduce or stop any <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/background-information/secondary-causes/\">drug treatment</a> that may be causing or contributing to symptoms, if possible and appropriate.</li><li>Advise on <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/management/adults/#initial-self-management\">lifestyle measures</a>, such as increasing dietary fibre, fluid intake, and activity levels.</li><li>Manage any <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/management/adults/#faecal-loading-and-or-impaction\">faecal loading and/or impaction</a> first, if present.</li></ul></li><li>If the person has ongoing symptoms despite these measures, offer drug treatment with oral laxatives using a stepped approach. Adjust the dose, choice, and combination of laxatives used, depending on the person's symptoms, the desired speed of symptom relief, the response to treatment, and their personal preference.<ul><li>Offer initial treatment with a bulk-forming laxative such as ispaghula. Note: it is important for the person to drink an adequate fluid intake.</li><li>If stools remain hard or difficult to pass, add or switch to an osmotic laxative, such as a macrogol.<ul><li>If a macrogol is ineffective or not tolerated, offer treatment with lactulose second-line.</li></ul></li><li>If stools are soft but difficult to pass or there is a sensation of inadequate emptying, add a stimulant laxative.</li><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/prescribing-information/\">Prescribing information</a> for more information on laxative choices and factors to consider before prescribing different laxatives.</li></ul></li><li>Consider treatment with prucalopride if at least two laxatives from different classes have been tried at the highest tolerated recommended doses for at least 6 months, and failed to relieve symptoms, where invasive treatment (such as suppositories, enemas, rectal irrigation and/or manual disimpaction) is being considered.<ul><li>The prokinetic prucalopride (a selective, high-affinity, serotonin [5HT4] receptor agonist) stimulates gastrointestinal motility. Offer a prescription for 4 weeks and if there is no symptom response following this trial, reconsider the benefit of continuing treatment.</li><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/prescribing-information/\">Prescribing information</a> for more information on prescribing prucalopride and factors to consider before prescribing it.</li></ul></li><li>If the person has opioid-induced constipation:<ul><li>Do not prescribe bulk-forming laxatives.</li><li>Offer an osmotic laxative and a stimulant laxative (or docusate is an alternative which also has stool-softening properties).</li></ul></li><li>Gradually titrate the laxative dose(s) up or down aiming to produce soft, formed stool without straining at least three times per week.</li><li>Arrange to review the person regularly, depending on clinical judgement. See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/management/adults/#follow-up-in-primary-care\">How should I follow up a person in primary care?</a> for more information.</li></ul><!-- end field 7146c388-a7a3-4858-ba4a-04f1e66e2278 --><!-- end item 6e5968c6-77a4-4926-abff-34000ba02dcb -->","subChapters":[{"id":"210f20e1-c551-54b5-9fc3-2ffdb4b90455","slug":"basis-for-recommendation-434","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 16430f2a-1431-453a-a9c7-9d083b462553 --><h4>Basis for recommendation</h4><!-- end field 16430f2a-1431-453a-a9c7-9d083b462553 -->","summary":null,"htmlStringContent":"<!-- begin item 4346876a-3de6-4a4e-a481-fd9ae796945c --><!-- begin field b4243948-0d3a-4f8c-af4d-ae6cac786c87 --><p>The recommendations on the management of chronic constipation are largely based on expert opinion in the World Gastroenterology Organisation (WGO) Global Guidelines <em>Constipation: a global perspective</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">WGO, 2010</a>], the Northern Ireland Centre for Pharmacy Learning and Development COMPASS publication <em>Therapeutic notes on the management of chronic constipation in primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">COMPASS, 2016</a>], the American Gastroenterological Association (AGA) <em>Medical position statement on constipation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Bharucha, 2013b</a>] and AGA <em>Technical review on constipation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Bharucha, 2013a</a>], the American College of Gastroenterology (ACG) <em>Monograph on the management of irritable bowel syndrome and chronic idiopathic constipation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Ford, 2014</a>], a Cochrane systematic review <em>Lactulose versus polyethylene glycol for chronic constipation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Lee-Robichaud et al, 2010</a>], systematic reviews of treatments for idiopathic chronic constipation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Lau, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Nelson, 2016</a>], expert opinion in review articles on constipation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Mounsey, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Roque, 2015</a>] and opioid-induced constipation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Goodheart and Leavitt, 2006</a>]. The recommendations on the use of prucalopride is largely based on the National Institute for Health and Care Excellence (NICE) technology appraisal <em>Prucalopride for the treatment of chronic constipation in women</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">NICE, 2010</a>].</p><h5>Choice of laxatives</h5><ul><li>There is some evidence that soluble fibre supplements can improve chronic constipation symptoms and stool frequency in people with chronic idiopathic constipation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Bharucha, 2013a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Ford, 2014</a>].</li><li>Evidence for the efficacy and safety of some of the older laxatives from well-designed trials is limited, as there is a lack of head-to-head comparative studies to determine whether one laxative class is superior to another [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Tack, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">COMPASS, 2016</a>].<ul><li>The AGA technical review notes that traditional bulk-forming, osmotic, and stimulant laxatives are effective and safe [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Bharucha, 2013a</a>].</li><li>A Cochrane systematic review meta-analysis of 10 randomized controlled trials (RCTs) in children and adults (n = 868) comparing lactulose and the macrogol polyethylene glycol (PEG) found that PEG was superior to lactulose in outcomes of stool frequency per week, stool consistency, abdominal pain, and the need for additional medication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Lee-Robichaud et al, 2010</a>].</li><li>This is supported by the ACG monograph which found high-quality evidence that PEG is effective in improving symptoms of chronic idiopathic constipation, low-quality evidence to support the use of lactulose, and moderate-quality evidence to support the use of stimulant laxatives [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Ford, 2014</a>].</li><li>In addition, a network meta-analysis of 21 RCTs (n = 9189) found bisacodyl, sodium picosulfate, and prucalopride were superior to placebo for the end-point of at least three complete spontaneous bowel movements per week, and it concluded that all drugs for the treatment of chronic idiopathic constipation show similar efficacy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Nelson, 2016</a>]. CKS notes that osmotic laxatives were not included in the analysis, as the end-points of those studies were not consistent with the inclusion criteria.</li></ul></li></ul><h5>Considering a trial of prucalopride </h5><ul><li>This recommendations is based on the NICE technology appraisals on prucalopride [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">NICE, 2010</a>].<ul><li>Prucalopride was associated with a statistically significant improvement in frequency of spontaneous, complete bowel movements after 12 weeks of treatment. Most people who will benefit from treatment with prucalopride will respond within four weeks.</li></ul></li><li>In addition, a subsequent systematic review of people with idiopathic chronic constipation found prucalopride was likely to be beneficial, and were more effective than placebo at improving frequency of defecation and spontaneous complete bowel movements. Included studies were, however, conducted in secondary and tertiary care and were predominantly in women, so the results may not be applicable to men or the primary care population in general [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Lau, 2015</a>].</li><li>The ACG monograph also found moderate-quality evidence that prucalopride is more effective than placebo in improving symptoms of chronic idiopathic constipation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Ford, 2014</a>].</li></ul><h5>Treating opioid-induced constipation</h5><ul><li>The recommendations on treating opioid-induced constipation are based on expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Goodheart and Leavitt, 2006</a>].<ul><li>Bulk-forming laxatives are not recommended as their mode of action is to distend the colon and stimulate peristalsis, but opioids prevent the colon responding with propulsive action. This may cause abdominal colic and rarely bowel obstruction.</li><li>Osmotic laxatives retain fluid in the stool making defecation easier, and docusate also has stool-softening properties.</li><li>Stimulant laxatives overcome the reduced peristalsis caused by opioid medication.</li></ul></li></ul><!-- end field b4243948-0d3a-4f8c-af4d-ae6cac786c87 --><!-- end item 4346876a-3de6-4a4e-a481-fd9ae796945c -->","subChapters":[]}]},{"id":"3cd12814-c591-533a-82a1-74f70b62dff9","slug":"faecal-loading-and-or-impaction","fullItemName":"Faecal loading and/or impaction","depth":3,"htmlHeader":"<!-- begin field e6479985-c3b6-4036-aeb4-9f7b40f19d00 --><h3>How should I manage faecal loading and/or impaction?</h3><!-- end field e6479985-c3b6-4036-aeb4-9f7b40f19d00 -->","summary":null,"htmlStringContent":"<!-- begin item e3ccd5d0-3b3a-4fc0-a4f1-36a8b43fe663 --><!-- begin field c75670ef-8c94-4d39-b28d-44f4bd1693f5 --><p>For the management of <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/diagnosis/diagnosis/\">faecal loading and/or impaction</a>, the aim is to achieve complete disimpaction with minimal discomfort. Adjust the dose, choice, and combination of laxatives used, depending on the person's response to treatment and their personal preference. Following an <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/diagnosis/assessment/\">assessment</a> including examination of the person:</p><ul><li>If there are hard stools, consider prescribing a high dose of an oral macrogol.</li><li>If there are soft stools, or ongoing hard stools after a few days of treatment with an oral macrogol, consider starting or adding an oral stimulant laxative.</li><li>If the response to oral laxatives is inadequate or too slow, consider prescribing:<ul><li>A suppository such as bisacodyl for soft stools; glycerol alone, or glycerol plus bisacodyl for hard stools.</li><li>A mini enema such as docusate (softener and weak stimulant) or sodium citrate (osmotic).</li><li>Note: enemas may need a district nurse or a carer to administer them. Warn the person that diarrhoea and faecal overflow may occur before disimpaction is complete.</li></ul></li><li>If the response to treatment is still inadequate, consider prescribing:<ul><li>A sodium phosphate or arachis oil retention enema (placed high if the rectum is empty but the colon is full).<ul><li>For hard stool it can be helpful to give the arachis oil enema overnight before giving a sodium phosphate (large volume) or sodium citrate (small volume) enema the next day.</li><li>Enemas may need to be repeated several times to clear hard, impacted faeces.</li></ul></li><li>Note: enemas may need a district nurse or a carer to administer them.</li></ul></li><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/prescribing-information/\">Prescribing information</a> for more information on laxative choices and factors to consider before prescribing different laxatives.</li><li>Reinforce advice on <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/management/adults/#initial-self-management\">lifestyle measures</a> such as increasing dietary fibre, fluid intake, and activity levels, to help maintain regular bowel movements and prevent recurrent faecal loading.</li><li>Consider the need for regular laxative use to maintain regular bowel movements, or the use of intermittent laxatives for episodes of faecal loading.<ul><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/management/adults/#chronic-constipation\">How should I manage chronic constipation?</a> for more information on regular laxative use.</li></ul></li><li>Arrange to review the person every few days to assess the response to treatment, depending on clinical judgement.</li></ul><!-- end field c75670ef-8c94-4d39-b28d-44f4bd1693f5 --><!-- end item e3ccd5d0-3b3a-4fc0-a4f1-36a8b43fe663 -->","subChapters":[{"id":"3f9817df-db0d-503e-8fa2-d79949613656","slug":"basis-for-recommendation-7e3","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 20388543-68da-4e02-87f6-cfe726c77fc9 --><h4>Basis for recommendation</h4><!-- end field 20388543-68da-4e02-87f6-cfe726c77fc9 -->","summary":null,"htmlStringContent":"<!-- begin item 7e3f8cba-e78d-42b1-ae64-1af21e39e63b --><!-- begin field df641a33-faa2-4e1b-8e98-1979f5967676 --><p>The recommendations on the management of faecal loading and/or impaction are largely based on the Northern Ireland Centre for Pharmacy Learning and Development COMPASS publication <em>Therapeutic notes on the management of chronic constipation in primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">COMPASS, 2016</a>] and expert opinion in a review article on the management of constipation in older adults [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Mounsey, 2015</a>].</p><!-- end field df641a33-faa2-4e1b-8e98-1979f5967676 --><!-- end item 7e3f8cba-e78d-42b1-ae64-1af21e39e63b -->","subChapters":[]}]},{"id":"1cd1b195-98bb-5aa0-9358-431d4461fe0f","slug":"pregnancy-breastfeeding","fullItemName":"Pregnancy and breastfeeding","depth":3,"htmlHeader":"<!-- begin field aa2591c1-d2f1-47e0-9bf1-a79100b4c646 --><h3>How should I manage constipation in pregnancy and breastfeeding?</h3><!-- end field aa2591c1-d2f1-47e0-9bf1-a79100b4c646 -->","summary":null,"htmlStringContent":"<!-- begin item 0143f9ae-9c02-4904-816a-a79100b4c0c7 --><!-- begin field 1e99638c-acda-499d-9343-a79100b4c646 --><p><strong>For the management of constipation during pregnancy:</strong></p><ul><li>Advise on sources of information and support, such as the UK Teratology Information Service (UKTIS) patient information leaflet <a href=\"http://www.medicinesinpregnancy.org/Medicine--pregnancy/Treating-constipation-during-pregnancy/\" target=\"_blank\" data-hyperlink-id=\"df5a7d5c-b9bb-4486-afe9-a99100392227\">Treating constipation during pregnancy</a>, available at <a href=\"http://www.medicinesinpregnancy.org/Medicine--pregnancy/Treating-constipation-during-pregnancy/#\" target=\"_blank\" data-hyperlink-id=\"4352f4f8-1131-4109-beff-a99100392249\">www.medicinesinpregnancy.org</a>.</li><li>Advise on <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/management/adults/#initial-self-management\">lifestyle measures</a>, such as increasing dietary fibre, fluid intake, and activity levels, as appropriate.</li><li>If these measures are ineffective, or symptoms do not respond adequately, offer short-term treatment with oral laxatives. Adjust the dose, choice, and combination of laxatives used, depending on the woman's symptoms, the desired speed of symptom relief, the response to treatment, and their personal preference.<ul><li>Offer a bulk-forming laxative first-line, such as ispaghula.</li><li>If stools remain hard, add or switch to an osmotic laxative, such as lactulose.</li><li>If stools are soft but difficult to pass, or there is a sensation of incomplete emptying, consider a short course of a stimulant such as senna.</li></ul></li><li>If the response to treatment is still inadequate, consider prescribing a glycerol suppository.</li><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/prescribing-information/\">Prescribing information</a> for more information on laxative choices and factors to consider before prescribing different laxatives.</li><li>If there is uncertainty about the use or safety of laxatives during pregnancy, contact the UKTIS:<ul><li>To discuss with a teratology specialist, telephone 0344 892 0909.</li><li>For information on the safety of specific laxatives, see the website at <a href=\"http://www.uktis.org/\" target=\"_blank\" data-hyperlink-id=\"003e0ff3-f0e7-4cf0-8e3c-a99100392253\">www.uktis.org</a>.</li></ul></li></ul><p><strong>For the management of constipation during breastfeeding:</strong></p><ul><li>Advise on sources of information and support, such as the Breastfeeding Network drug factsheet <a href=\"https://breastfeedingnetwork.org.uk/wp-content/dibm/constipation%20and%20breastfeeding.pdf\" target=\"_blank\" data-hyperlink-id=\"df708290-d3d6-4887-b8d6-a991003922c9\">Constipation treatment in breastfeeding mothers</a>, available at <a href=\"https://www.breastfeedingnetwork.org.uk/\" target=\"_blank\" data-hyperlink-id=\"de95853b-e923-4e98-860a-a991003922e8\">www.breastfeedingnetwork.org.uk</a>.</li><li>Advise on <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/management/adults/#initial-self-management\">lifestyle measures</a>, such as increasing dietary fibre, fluid intake, and activity levels, as appropriate.</li><li>If these measures are ineffective, or symptoms do not respond adequately, offer short-term treatment with oral laxatives. Adjust the dose, choice, and combination of laxatives used, depending on the woman's symptoms, the desired speed of symptom relief, the response to treatment, and their personal preference.<ul><li>Offer a bulk-forming laxative first-line, such as ispaghula. </li><li>If stools remain hard or difficult to pass, add or switch to an osmotic laxative such as lactulose or a macrogol.</li><li>If stools are soft but difficult to pass or there is a sensation of inadequate emptying, consider a short course of a stimulant laxative such as bisacodyl or senna.</li></ul></li><li>If the response to treatment is still inadequate, consider prescribing a glycerol suppository.</li><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/prescribing-information/\">Prescribing information</a> for more information on laxative choices and factors to consider before prescribing different laxatives.</li><li>If there is uncertainty about the use or safety of laxatives during breastfeeding, contact the UK Drugs in Lactation Advisory Service (UKDILAS) provided by the UK Medicines Information Network:<ul><li>To discuss with a specialist pharmacist, telephone 0116 2586491 or 0121 4247298.</li><li>For information on the safety of specific laxatives, see the website at <a href=\"https://www.sps.nhs.uk/articles/safety-in-lactation-laxatives/\" target=\"_blank\" data-hyperlink-id=\"690a9147-ba3b-46fc-ae9a-a991003923f9\">www.sps.nhs.uk</a>.</li></ul></li></ul><!-- end field 1e99638c-acda-499d-9343-a79100b4c646 --><!-- end item 0143f9ae-9c02-4904-816a-a79100b4c0c7 -->","subChapters":[{"id":"51bc1db1-5a88-5d9b-932f-6b063b0eb1e4","slug":"basis-for-recommendation-a0f","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 8e30f19b-78d4-4ea5-a898-a79100b4c6de --><h4>Basis for recommendation</h4><!-- end field 8e30f19b-78d4-4ea5-a898-a79100b4c6de -->","summary":null,"htmlStringContent":"<!-- begin item a0f2fe7f-aa89-4793-9025-a79100b4c6d0 --><!-- begin field a2e7f122-5e1b-4a05-b000-a79100b4c6de --><p>The recommendations on the management of constipation in pregnancy are largely based on expert opinion in the UK Teratology Information Service (UKTIS) monograph <em>Treatment of constipation in pregnancy</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">UKTIS, 2013</a>] and the Cochrane systematic review <em>Interventions for treating constipation in pregnancy (Review)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Rungsiprakarn, 2015</a>]. The recommendations on the management of constipation while breastfeeding are largely based on expert opinion published by the Specialist Pharmacy Service <em>Safety in lactation: Laxatives</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">SPS, 2017</a>] and the Cochrane systematic review <em>Interventions for treating postpartum constipation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Turawa, 2014</a>].</p><h5>Management in pregnancy</h5><ul><li>The UKTIS monograph notes that there is very little epidemiological information on the potential risks associated with laxative use in pregnancy, however most laxatives have minimal systemic absorption and are commonly used during pregnancy. If needed, they should only be used for short time periods, as they may induce electrolyte imbalance during pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">UKTIS, 2013</a>].<ul><li>No adverse fetal effects have been reported following the use of bulk-forming laxatives during pregnancy.</li><li>There are no data regarding the use of lactulose in pregnancy, but the manufacturers state its use may be considered if necessary.</li><li>There are very limited data on the use of senna and docusate in pregnancy, which suggest no increased risk of congenital malformations.</li><li>There are no published data on the use of macrogols, bisacodyl, sodium picosulfate, glycerine suppositories, or enemas in pregnancy.</li></ul></li><li>In addition, a Cochrane systematic review of two randomized controlled trials (RCTs) or quasi-RCTs (noted to be unclear, n = 180) examined fibre supplementation versus no intervention, and stimulant versus bulk-forming laxatives, and found [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Rungsiprakarn, 2015</a>]:<ul><li>Moderate-quality evidence from one small study (n = 40) that women who took fibre supplementation had a higher frequency of stools and improved stool consistency compared with no intervention</li><li>Moderate-quality evidence from one study (n = 140) that compared with bulk-forming laxatives, women who used stimulant laxatives such as senna had an improvement in constipation symptoms, but no clear difference in satisfaction rates between the two treatments.</li><li>There were no data to compare other interventions such as osmotic, stool softener, or lubricant laxatives, enemas or suppositories.</li><li>It concluded that there was insufficient evidence to fully assess the efficacy and safety of drug and non-drug treatments for constipation in pregnancy due to limited data which used different outcome measures, a meta-analysis was not possible due to the small number of studies, and the studies were at moderate risk of bias.</li></ul></li></ul><h5>Management in breastfeeding</h5><ul><li>The SPS publication notes that various laxatives can be used short-term when breastfeeding infants one month of age or older [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">SPS, 2017</a>]:<ul><li>Bulk-forming laxatives are not absorbed from the gastrointestinal tract and are considered compatible with breastfeeding.</li><li>Short-term use of osmotic laxatives is not considered to pose a risk to infants when breastfeeding, as they are minimally absorbed by the mother and infant.</li><li>The stimulant laxatives bisacodyl and sodium picosulfate are not absorbed from the gastrointestinal tract, and their common active metabolite is undetectable in breast milk. The SPS notes that senna may cause diarrhoea and abdominal cramps, but this has not been confirmed as an issue in controlled trials in breastfed infants, and the active ingredient is undetectable in breast milk.</li><li>Docusate has minimal absorption from the gastrointestinal tract for the mother and infant, and can be used while breastfeeding.</li><li>Glycerol suppositories are likely to be degraded in the mother's gastrointestinal tract, and are safe to use in breastfeeding. Sodium citrate enemas may be considered for use when breastfeeding.</li></ul></li><li>A Cochrane systematic review of any educational, behavioural, laxative, or surgical intervention for the treatment of postpartum constipation did not find any relevant RCTs for inclusion, so it could not draw any conclusions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Turawa, 2014</a>].</li></ul><!-- end field a2e7f122-5e1b-4a05-b000-a79100b4c6de --><!-- end item a0f2fe7f-aa89-4793-9025-a79100b4c6d0 -->","subChapters":[]}]},{"id":"303d81db-4f71-5638-a502-d634380b70cf","slug":"follow-up-in-primary-care","fullItemName":"Follow-up in primary care","depth":3,"htmlHeader":"<!-- begin field d4175fb4-294f-4009-b454-9fbefd8d543e --><h3>How should I follow up a person in primary care?</h3><!-- end field d4175fb4-294f-4009-b454-9fbefd8d543e -->","summary":null,"htmlStringContent":"<!-- begin item 909d55a2-86cb-45a4-9703-116fadc92ce7 --><!-- begin field e0d2c771-d3cd-42bb-9331-781718bb0948 --><p><strong>Arrange regular follow-up of the person depending on clinical judgement.</strong></p><ul><li><strong>If oral laxatives have been prescribed, advise that:</strong><ul><li>Laxatives should not be stopped suddenly, and weaning off all laxatives may take several months. The rate of laxative dose reduction should be guided by the frequency and consistency of stools.</li><li>Laxative doses should be reduced gradually, for example after 2–4 weeks when regular bowel movements are comfortable, with soft formed stools.<ul><li>This is to minimize the risk of requiring rescue laxative treatment for recurrent <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/management/adults/#faecal-loading-and-or-impaction\">faecal loading and/or impaction</a>.</li><li>If a combination of laxatives has been used, reduce and stop one laxative at a time, starting with stimulant laxatives, if possible. Note: it may be necessary to also adjust the dose of other laxatives used to maintain regular bowel movements.</li></ul></li><li>Relapses are common and should be treated early with increased doses of laxatives.</li><li>Laxatives may need to be continued long term for people with a medical condition or taking a medication (if it cannot be reduced or stopped) causing <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/background-information/secondary-causes/\">secondary constipation</a>.</li></ul></li><li><strong>If symptoms are ongoing or refractory</strong> to laxative treatment, consider:<ul><li>Checking blood tests for full blood count, thyroid function tests, HbA1c, and serum electrolytes and calcium, to look for an <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/background-information/secondary-causes/\">underlying cause</a>, and manage appropriately.</li><li>Whether a defecatory disorder, such as <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/background-information/definition/\">pelvic floor dyssynergia</a>, may be contributory.</li></ul></li><li><strong>Seek specialist advice or arrange referral to a gastroenterologist or colorectal surgeon for <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/management/adults/#specialist-investigations-management\">specialist investigations and management</a>, depending on clinical judgement, if:</strong><ul><li>A serious underlying cause such as colorectal cancer is suspected. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/gastrointestinal-tract-lower-cancers-recognition-referral/\">Gastrointestinal tract (lower) cancers - recognition and referral</a> for more information.</li><li>An underlying <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/background-information/secondary-causes/\">secondary cause</a> of constipation is suspected, which cannot be managed in primary care.</li><li>Symptoms persist or recur despite optimal management in primary care.</li></ul></li><li><strong>Arrange referral to a local continence service</strong> (if available) if there are symptoms of faecal incontinence which have been fully investigated and are ongoing.</li><li><strong>Arrange referral to a dietitian</strong> if support with dietary changes and increasing fibre content is needed.</li></ul><!-- end field e0d2c771-d3cd-42bb-9331-781718bb0948 --><!-- end item 909d55a2-86cb-45a4-9703-116fadc92ce7 -->","subChapters":[{"id":"9cf9042a-7be2-54a6-aa0a-98dc35a39fb7","slug":"specialist-investigations-management","fullItemName":"Specialist investigations and management","depth":4,"htmlHeader":"<!-- begin field 5b124ecf-dabc-4137-bb29-a7920175b720 --><h4>What specialist investigations and management are available?</h4><!-- end field 5b124ecf-dabc-4137-bb29-a7920175b720 -->","summary":null,"htmlStringContent":"<!-- begin item 5c7ae38a-45b0-41fe-a3b7-a7920175b05a --><!-- begin field c8febf2e-4943-4e19-aa9b-a7920175b720 --><p><strong>Following <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/management/adults/#follow-up-in-primary-care\">referral</a> to a gastroenterologist or colorectal surgeon:</strong></p><ul><li><strong>Specialist investigations may include:</strong><ul><li>Flexible sigmoidoscopy, colonoscopy or computed tomographic colonography; abdominal X-ray may identify faecal load, impaction, or obstruction.</li><li>Anorectal manometry, defecation proctogram, and colon transit time studies with radio-opaque markers or a wireless capsule to determine which <a class=\"topic-reference internal-reference\" href=\"/topics/constipation/background-information/definition/\">subtype</a> of constipation is involved, such as slow colonic transit or pelvic floor dyssynergia.</li></ul></li><li><strong>Specialist management may include:</strong><ul><li>Biofeedback training by a physiotherapist for some defecation disorders, such as pelvic floor dyssynergia, which can teach people to relax their pelvic floor muscles during simulated defecation.</li><li>Surgery, such as subtotal colectomy with ileorectal anastomosis, may be considered rarely in people with slow transit constipation if all other treatment options have been ineffective.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Jamshed, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Tack, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Ford, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Woodward, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Roque, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Wald, 2016</a>]</p><!-- end field c8febf2e-4943-4e19-aa9b-a7920175b720 --><!-- end item 5c7ae38a-45b0-41fe-a3b7-a7920175b05a -->","subChapters":[]},{"id":"f379f529-647f-53bf-ba66-b860383abdcd","slug":"basis-for-recommendation-27a","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 32c298e2-a5c2-4db7-99f9-564ccc8aa9e4 --><h4>Basis for recommendation</h4><!-- end field 32c298e2-a5c2-4db7-99f9-564ccc8aa9e4 -->","summary":null,"htmlStringContent":"<!-- begin item 27ac6b51-a49e-4e88-8827-8e0583187df0 --><!-- begin field 42213650-65d7-4291-aa76-a5c503031fd8 --><p>The recommendations on primary care follow-up are based on expert opinion in the World Gastroenterology Organisation (WGO) Global Guidelines <em>Constipation: a global perspective</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">WGO, 2010</a>], the Northern Ireland Centre for Pharmacy Learning and Development COMPASS publication <em>Therapeutic notes on the management of chronic constipation in primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">COMPASS, 2016</a>], the American Gastroenterological Association (AGA) <em>Medical position statement on constipation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Bharucha, 2013b</a>], and expert opinion in review articles on the diagnosis and treatment of constipation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Jamshed, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Tack, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Roque, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Wald, 2016</a>].</p><h5>Advice on weaning off laxatives</h5><ul><li>The recommendations on reducing laxative doses are largely based on the COMPASS publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">COMPASS, 2016</a>].</li></ul><h5>Arranging blood tests to exclude a secondary cause</h5><ul><li>This recommendation is based on expert opinion in the WGO guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">WGO, 2010</a>], expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Tack, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Roque, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Wald, 2016</a>] and is pragmatic, based on what CKS considers to be good clinical practice.</li></ul><h5>Considering a diagnosis of a defecatory disorder</h5><ul><li>The recommendation on considering the diagnosis of a defecatory disorder if symptoms do not respond to oral laxatives in primary care is based on expert opinion in the WGO guideline and the AGA guideline, as defecation disorders do not typically respond well to standard laxative treatment and may be a cause of treatment failure [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">WGO, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Bharucha, 2013b</a>].</li></ul><h5>Seeking specialist advice or arranging referral</h5><ul><li>The recommendation on referral if there is suspected colorectal cancer is based on the National Institute for Health and Care Excellence (NICE) clinical guideline <em>Suspected cancer: recognition and referral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">NICE, 2015</a>].</li><li>The recommendation on referral if there are persistent or refractory symptoms is based on the AGA and COMPASS guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Bharucha, 2013b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">COMPASS, 2016</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Jamshed, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/constipation/references/\">Roque, 2015</a>].</li><li>The recommendations on referral to a local continence service or dietitian are pragmatic, based on what CKS considers to be good clinical practice.</li></ul><!-- end field 42213650-65d7-4291-aa76-a5c503031fd8 --><!-- end item 27ac6b51-a49e-4e88-8827-8e0583187df0 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}